Skip to content

Ketamine for addiction: all studies

Page 15 of 15: studies 141 to 144 of 144, newest first. Back to the ketamine for addiction overview

Research

The nonmedical use of ketamine, part two: A review of problem use and dependence.

Journal of Psychoactive Drugs 2001 K L Jansen, R Darracot-Cankovic

This is the second part of a review of the nonmedical use of ketamine. Part one discussed the history of ketamine, the sought-after effects for which it is taken in a nonmedical context, how these are produced, common adverse effects, the ketamine schizophrenia model and the neurotoxicity issue. Part two reviews what is currently known about problem use of ketamine, ketamine dependence,...

Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research

Journal of Psychoactive Drugs June 1, 1997 Evgeny Krupitsky, Alexander Grinenko 241 citations

Ketamine is a prescription drug used for general anesthesia. In subanesthetic doses, it induces profound psychedelic experiences and hallucinations. The subanesthetic effect of ketamine was the hypothesized therapeutic mechanism in the authors' use of ketamine-assisted psychotherapy for alcoholism. The results of a controlled clinical trial demonstrated a considerable increase in efficacy of...

Behavioral dependence upon phencyclidine and ketamine in the rat.

Journal of Pharmacology and Experimental Therapeutics July 1, 1987 Patrick M. Beardsley, R. Balster

The present studies examined whether dependence could be induced by continuous i.v. infusion of phencyclidine (PCP) in rats as demonstrated by disruptions of operant behavior during withdrawal. Rats were trained to lever press for their daily food rations under fixed-ratio 30 schedules of reinforcement during four, daily, 0.5-hr sessions. In the first study, withdrawal from 10 days of PCP...

Co-Boost: Boosting and guiding neuroplasticity by combining ketamine with neurofeedback-assisted learning – towards an individualised and integrated pharmaco-psychotherapy for cocaine addiction: study protocol for a randomised, placebo-controlled, double-blind, parallel-group, single-centre trial

Anna Stefania Trippel, Ladina Philomena Gubser, Etna Jennifer Elektra Engeli et al. preprint

Abstract Background: Cocaine is the most frequently used stimulant worldwide, with increasing consumption rates in Europe. Cocaine use is associated with great harm to individuals and society. As of today, psychotherapeutic interventions for cocaine use disorder (CUD) demonstrate only modest effect sizes, and no pharmacotherapy has been approved due to gaps in understanding the disease....